<< rosenblatt | ALL News

IMAX (NYSE:IMAX) Stock Rating Reaffirmed as "Buy" by Rosenblatt Securities

IMAX (NYSE:IMAX) Stock Rating Reaffirmed as "Buy" by Rosenblatt Securities
Analyst Bio:

IMAX (NYSE:IMAX)'s stock had its "buy" rating restated by equities research analysts at Rosenblatt Securities in a report issued on Wednesday, Benzinga reports. They currently have a $65.00 target price on the stock. Rosenblatt Securities' price objective would indicate a potential upside of 27.75% from the company's current price.

‍

Link to full article